SFN and type 1 diabetes mellitus: Pyruvate kinase (10-fold) (p<0.001) and ACBP (2-fold) (p<0.01) expression in T1D patients was up-regulated compared with controls (Figure 2B); while stratifin was not detectable in control patients it was highly expressed in T1D (p<0.001), (Figure 2C).